These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15085910)

  • 1. Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients.
    Lobo FS; Gross CR; Matthees BJ
    Qual Life Res; 2004 Mar; 13(2):377-88. PubMed ID: 15085910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
    Pickard AS; Wang Z; Walton SM; Lee TA
    Health Qual Life Outcomes; 2005 Mar; 3():11. PubMed ID: 15748287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain.
    Hollingworth W; Deyo RA; Sullivan SD; Emerson SS; Gray DT; Jarvik JG
    Health Econ; 2002 Jan; 11(1):71-85. PubMed ID: 11788983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients.
    Rashidi AA; Anis AH; Marra CA
    Health Qual Life Outcomes; 2006 Apr; 4():25. PubMed ID: 16626489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing health-related quality of life in cataract patients: the relationship between utility and health-related quality of life measurement.
    Lee JE; Fos PJ; Zuniga MA; Kastl PR; Sung JH
    Qual Life Res; 2000; 9(10):1127-35. PubMed ID: 11401045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs).
    Brunner HI; Maker D; Grundland B; Young NL; Blanchette V; Stain AM; Feldman BM
    Med Decis Making; 2003; 23(4):314-22. PubMed ID: 12926581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung Transplantation.
    Singer LG; Chowdhury NA; Faughnan ME; Granton J; Keshavjee S; Marras TK; Tullis DE; Waddell TK; Tomlinson G
    Am J Respir Crit Care Med; 2015 Oct; 192(8):965-73. PubMed ID: 26131729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of measured utility scores and imputed scores from the SF-36 in patients with rheumatoid arthritis.
    Kaplan RM; Groessl EJ; Sengupta N; Sieber WJ; Ganiats TG
    Med Care; 2005 Jan; 43(1):79-87. PubMed ID: 15626937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and interpretation of preference-based measures of health-related quality of life.
    Lenert L; Kaplan RM
    Med Care; 2000 Sep; 38(9 Suppl):II138-50. PubMed ID: 10982099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
    Richardson SS; Berven S
    Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index.
    O'Brien BJ; Spath M; Blackhouse G; Severens JL; Dorian P; Brazier J
    Health Econ; 2003 Nov; 12(11):975-81. PubMed ID: 14601159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life after lung transplantation: a cross-sectional study.
    Smeritschnig B; Jaksch P; Kocher A; Seebacher G; Aigner C; Mazhar S; Klepetko W
    J Heart Lung Transplant; 2005 Apr; 24(4):474-80. PubMed ID: 15797751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The standard gamble showed better construct validity than the time trade-off.
    Puhan MA; Schünemann HJ; Wong E; Griffith L; Guyatt GH
    J Clin Epidemiol; 2007 Oct; 60(10):1029-33. PubMed ID: 17884597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the EQ-5D in patients with irritable bowel syndrome.
    Bushnell DM; Martin ML; Ricci JF; Bracco A
    Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
    Huang IC; Willke RJ; Atkinson MJ; Lenderking WR; Frangakis C; Wu AW
    Qual Life Res; 2007 Aug; 16(6):1065-72. PubMed ID: 17415683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates.
    Singer LG; Theodore J; Gould MK
    Med Decis Making; 2003; 23(5):435-40. PubMed ID: 14570301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.
    Khanna D; Furst DE; Wong WK; Tsevat J; Clements PJ; Park GS; Postlethwaite AE; Ahmed M; Ginsburg S; Hays RD;
    Qual Life Res; 2007 Aug; 16(6):1083-92. PubMed ID: 17404896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.